Heightened cutaneous reactions to mosquito bites in patients with acquired immunodeficiency syndrome receiving zidovudine.
Three patients with acquired immunodeficiency syndrome noted changing cutaneous reactions to mosquito bites one to three months after starting zidovudine therapy. Enhanced T-cell function is one possibility for the heightened response to mosquito bites in these patients.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D000328:Adult; D000818:Animals; D009033:Culicidae; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D006969:Hypersensitivity, Immediate / Q000139:chemically induced*; D007299:Insect Bites and Stings / Q000276:immunology*; D007958:Leukocyte Count; D008297:Male; D013601:T-Lymphocytes / Q000276:immunology; D015215:Zidovudine / Q000009:adverse effects*
D015215:Zidovudine